Trial Profile
An open-label, randomized, single dose, two period, crossover study to determine the relative bioavailability of valsartan 160 mg Japanese formulation and valsartan 160 mg global formulation in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2007
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Essential hypertension; Heart failure; Hypertension; Postmyocardial infarction
- Focus Pharmacokinetics
- Sponsors Novartis
- 29 Mar 2007 New trial record.